GLI1 and cancer: It is noteworthy that although the involvement of GLI1 and HH pathway in HSC-3 is also supported by our previous study using GANT-61 inhibitor [12], additional GLI1 gene editing studies could constitute the proof-of-concept of its role in the cancer context.